Does GLP-1 Drug Tirzepatide Trigger Hair Loss? Experts Weigh In
Overview
Hair shedding has become one of the most talked-about side effects among people using GLP-1 receptor agonists for weight loss. A new study adds to that conversation, finding that the side effect is more likely to occur in patients taking one specific type of GLP-1 receptor agonist compared to others in the same drug class. The findings have prompted dermatologists and endocrinologists to weigh in on what patients should actually expect.
What the New Study Found
Researchers behind the study set out to compare hair loss reports across different GLP-1 medications rather than treating the drug class as a single, uniform risk. The result: not all GLP-1 receptor agonists appear to carry the same likelihood of triggering noticeable shedding. This distinction matters because tirzepatide, sold under brand names like Zepbound and Mounjaro, works slightly differently from other GLP-1 drugs by also targeting the GIP receptor, which some experts suspect may influence how the body responds during rapid weight change.
Why GLP-1 Drugs Can Affect Hair Growth
Hair loss linked to GLP-1 medications is generally not caused by the drug attacking hair follicles directly. Instead, dermatologists point to a condition called telogen effluvium, a temporary form of shedding triggered by physical stress on the body. Rapid or significant weight loss, calorie restriction, and nutrient shifts can push a larger-than-normal percentage of hair follicles into the "resting" (telogen) phase simultaneously, leading to noticeable shedding two to four months after the triggering event. Because GLP-1 drugs are specifically designed to produce fast, substantial weight loss, patients on these medications are considered more susceptible to this type of shedding than the general population.
Tirzepatide vs. Other GLP-1 Drugs
The comparative nature of the new research is what sets it apart from earlier anecdotal reports. Rather than simply confirming that GLP-1 drugs can cause hair loss, it attempts to identify whether the rate or severity differs between medications. Speed and magnitude of weight loss, along with individual factors like baseline nutrition and genetics, likely play a role in why some patients on one GLP-1 drug report more shedding than those on another.
What Experts Recommend
Dermatologists interviewed on the topic generally advise patients experiencing shedding to prioritize adequate protein intake, monitor for deficiencies in iron, zinc, and vitamin D as weight loss progresses, and consult a doctor before assuming the medication is solely to blame, since thyroid issues and other conditions can also cause hair loss. Most experts agree that telogen effluvium tied to weight loss is temporary, with regrowth typically occurring once weight stabilizes and nutrient intake normalizes.
FAQ
Is GLP-1-related hair loss permanent? In most documented cases, no. It is classified as temporary shedding that resolves as the body adjusts.
Should I stop taking my medication if I notice shedding? Experts recommend speaking with a prescribing doctor before making any changes rather than stopping treatment independently.
Source
Originally published at www.allure.com.